Allosteric Activation of the Follicle-stimulating Hormone (FSH) Receptor by Selective, Nonpeptide Agonists

The pituitary glycoprotein hormones, luteinizing hormone and follicle-stimulating hormone (FSH), act through their cognate receptors to initiate a series of coordinated physiological events that results in germ cell maturation. Given the importance of FSH in regulating folliculogenesis and fertility...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of biological chemistry 2006-05, Vol.281 (19), p.13226-13233
Main Authors: Yanofsky, Stephen D., Shen, Emily S., Holden, Frank, Whitehorn, Erik, Aguilar, Barbara, Tate, Emily, Holmes, Christopher P., Scheuerman, Randall, MacLean, Derek, Wu, May M., Frail, Donald E., López, Francisco J., Winneker, Richard, Arey, Brian J., Barrett, Ronald W.
Format: Article
Language:English
Subjects:
Allosteric Regulation - drug effects
Animals
Cell Line
Combinatorial Chemistry Techniques
Cricetinae
Estradiol - metabolism
Female
Follicle Stimulating Hormone - pharmacology
Granulosa Cells - drug effects
Granulosa Cells - metabolism
Humans
Mice
Molecular Structure
Progesterone - metabolism
Rats
Receptors, FSH - agonists
Receptors, FSH - metabolism
Structure-Activity Relationship
Thiazolidinediones - chemistry
Thiazolidinediones - pharmacology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The pituitary glycoprotein hormones, luteinizing hormone and follicle-stimulating hormone (FSH), act through their cognate receptors to initiate a series of coordinated physiological events that results in germ cell maturation. Given the importance of FSH in regulating folliculogenesis and fertility, the development of FSH mimetics has been sought to treat infertility. Currently, purified and recombinant human FSH are the only FSH receptor (FSH-R) agonists available for infertility treatment. By screening unbiased combinatorial chemistry libraries, using a cAMP-responsive luciferase reporter assay, we discovered thiazolidinone agonists (EC50's = 20 μm) of the human FSH-R. Subsequent analog library screening and parallel synthesis optimization resulted in the identification of a potent agonist (EC50 = 2 nm) with full efficacy compared with FSH that was FSH-R-selective and -dependent. The compound mediated progesterone production in Y1 cells transfected with the human FSH-R (EC50 = 980 nm) and estradiol production from primary rat ovarian granulosa cells (EC50 = 10.5 nm). This and related compounds did not compete with FSH for binding to the FSH-R. Use of human FSH/thyroid-stimulating hormone (TSH) receptor chimeras suggested a novel mechanism for receptor activation through a binding site independent of the natural hormone binding site. This study is the first report of a high affinity small molecule agonist that activates a glycoprotein hormone receptor through an allosteric mechanism. The small molecule FSH receptor agonists described here could lead to an oral alternative to the current parenteral FSH treatments used clinically to induce ovarian stimulation for both in vivo and in vitro fertilization therapy.
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.M600601200